Market revenue in 2023 | USD 6.2 million |
Market revenue in 2030 | USD 13.3 million |
Growth rate | 11.4% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-House, Outsourcing |
Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 62.9% in 2023. Horizon Databook has segmented the Thailand pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
Thailand is one of the fastest-growing economies globally and the second largest across Southeast Asia. The country offers low-cost manufacturing activities, witnessing a steady increase in pharmaceutical services.
Pharmaceutical companies in Thailand are experiencing the impact of a growing elderly population, which is more susceptible to health issues, such as stroke, heart ailments, cancer, and diabetes. According to the Office of the National Economic & Social Development Board, the number of people aged over 60 is projected to reach approximately 13.5 million in 2023.
The pharmaceutical sterility testing market in Thailand is driven by significant R&D spending in the country. Moreover, the presence of major early-stage development CROs, such as Charles River Laboratories and Envigo, is expected to drive market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into Thailand pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account